Background. There are no data comparing the Modification of Diet in Renal Disease (MDRD) Study and the Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) Study equations in the evaluation of timedependent trend of estimated glomerular filtration rate (eGFR) in the general population. Methods. Changes in eGFR and in the association of eGFR with kidney disease and cardiovascular disease (CVD) risk factors across age groups were estimated in two independent cross-sectional population surveys in Finland in 2002 and 2007 with 11 277 study participants, aged 25-74 years, using both the MDRD and the CKD-EPI equations. Results. A trend towards decreasing eGFRs between the study years was observed using both equations, but the trend was more substantial when using the MDRD equation. The MDRD equation yielded lower estimates of eGFR than the CKD-EPI equation, with small mean difference between the equations at low eGFR level but substantial at the level of only mildly decreased or nearnormal to normal kidney function. Decrease of eGFR was associated with an increase in CKD and CVD risk factors. However, an increase of risk factors was not observed among those who had mildly decreased eGFR by only the MDRD equation but not by the CKD-EPI equation. Conclusion. In comparison with the CKD-EPI equation, the MDRD equation augmented the trend of increasing prevalence of CKD, showed a weaker association with risk factors and tended to assign impaired renal function to individuals without an excess of cardiovascular risk factors.
Introduction
Early and accurate recognition of impaired renal function is an important issue in public health. In epidemiological studies and screening, the staging of chronic kidney disease (CKD) often relies upon glomerular filtration rate (GFR) estimating equations because of the simplicity of sampling, although other signs of kidney damage, such as albuminuria, should also be sought [1] . The method for estimating GFR should be validated in each population before applying it in epidemiological studies or clinical use [2] . The performance of the Modification of Diet in Renal Disease (MDRD) equation varies by population [3] . The GFR estimating equations may result in unreliable prevalence estimates of decreased GFR [4] .
The Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) Study equation has been observed to be more accurate than the MDRD Study equation in subjects with measured GFR ≥ 60 mL/min/1.73 m 2 [5] . Additionally, the CKD-EPI equation is regarded to more appropriately categorize individuals at risk for CKD and cardiovascular disease (CVD) in middle-aged population with normal or near-normal kidney function [6] . However, the CKD-EPI equation has not been applied to the evaluation of population trends of estimated GFR (eGFR).
End-stage renal disease has a prominent impact on cardiovascular health, showing increased risk for various CVD events and CVD mortality. It is reasonable to presume that this risk expresses continuity with a mildly increased CVD risk already in the earlier stages of renal impairment. Therefore, early recognition of even mild renal impairment is of great importance in public health.
We hypothesized that the CKD-EPI equation might perform better than the MDRD equation in assessing the trend of eGFR in the Finnish population. Data from two population surveys conducted in 2002 and 2007 were used for comparing the performance of the two equations. We also compared the strength of the association of eGFR, determined by either the MDRD or the CKD-EPI equations, with the prevalences of CVD risk factors and the estimated 10-year risk of fatal CVD.
Materials and methods

Study population
Two independent cross-sectional population surveys were conducted in Finland in 2002 and 2007 (the National FINRISK Study) [7] . The study areas included the provinces of North Karelia and Northern Savo in eastern Finland, the region of Turku-Loimaa in south-western Finland, the cities of Helsinki and Vantaa in southern Finland and the province of Oulu in northern Finland. Random samples of people aged 25-74 years were drawn in each survey from the national population register so that 250 persons in 2002 and 200 persons in 2007 were chosen for each sex and 10-year age stratum in each area. In 2002, serum creatinine was determined in all participants aged 25-64 years but among those aged 65-74 years serum creatinine was determined only in participants of North Karelia and the cities of Helsinki and Vantaa. In 2007, all participants of the FINRISK 2007 survey were invited to a sub-study including serum creatinine measurements. The response rate in the sub-study of the FINRISK 2007 survey was 71 % in men and 74 % in women. For the purposes of this article, participants aged 65-74 years were included in the analyses only in those regions where serum creatinine measurements were available in both surveys. The total number of participants in these two National FINRISK surveys was 13 579. The participation rates decreased over time from 66 to 62 % in men and from 75 to 71 % in women. A total of 11 277 people with complete data on serum creatinine were included in the analyses of the present study.
Measurements and definitions
The survey methods were carefully standardized following the recommendation by the European Health Risk Monitoring Project [8] . The surveys were conducted according to the ethical rules of the National Public Health Institute and the Declaration of Helsinki. Ethics approval was received from the co-ordinating Ethics Committee of the Helsinki University Hospital District. The participants signed an informed consent.
Information on medical history and health behaviour was obtained from a self-administered questionnaire. Prior CVD was regarded to be present if a subject reported to have had a prior myocardial infarction or an ischaemic stroke, if a coronary intervention had been performed or if a subject reported the symptoms of a serious CVD event. Self-reported diabetes was recorded. The participant was classified as a current smoker if having smoked regularly cigarettes, cigars or pipe for at least 1 year and if having smoked during the preceding month.
Blood pressure, height, weight and waist circumference were measured by nurses specially trained for the survey. Blood pressure was measured three times from the right arm of the participant who was seated for 5 min before the measurement. A person was considered to have hypertension if the average systolic blood pressure was at least 140 mmHg or diastolic 90 mmHg or if she or he reported having taken antihypertensive drugs during the preceding week.
Weight was measured with light clothing. Height was measured without shoes. Waist circumference was measured from midway between the inferior margin of the last rib and the iliac crest. Gender-specific standardized waist circumferences were calculated so that the mean was zero and the variance and SD were 1.0 for both men and women. Body mass index (BMI) was used as a measure of relative weight. Obesity was defined as BMI ≥ 30 kg/m 2 . The 10-year risk of fatal CVD was estimated according to the equations of the Systematic Coronary Risk Evaluation project (SCORE) [9] . The information to calculate the risk was missing in 34 of 11 277 subjects.
In 
Estimation of GFR
The eGFR was calculated by using both the abbreviated MDRD Study formula [10] and the CKD-EPI equation [11] . When serum creatinine (sCrea) is expressed in mg/dL (if expressed in mmol/L, divide by 88.4 to convert to mg/dL) and age in years, the MDRD equation yields: GFR = 175 × sCrea [12] .
Statistical analyses
Data analyses were conducted using SPSS for Windows version 19.0 (SPSS Inc., Chicago, IL). Differences between the mean values of the continuous variables were evaluated using Student's two-tailed t-test and between the dichotomous variables using the chi-square test. The bivariate correlations between variables were evaluated using Spearman's correlations between the number of risk factors and eGFR, otherwise using Pearson's correlations. The kappa statistics was used to evaluate the concordance between the eGFR classification by the MDRD and CKD-EPI equations. A logistic regression analysis, adjusted for age, gender, study year and study area, was performed to evaluate the associations of eGFR < 60 mL/min/1.73 m 2 with CKD and CVD risk factors. Linear regression was performed to study the relationship between 10-year risk of CVD death (SCORE estimate) and eGFR according to the MDRD and CKD-EPI equations in men and women. A P-value < 0.050 was considered statistically significant.
Results
The participants were slightly older in 2007 than in 2002 (Table 1) The difference in GFR estimates produced using the two formulae was small in study participants with low eGFR but large in study participants with only mildly decreased or near-normal to normal kidney function ( Figure 2 ). On average, eGFR-MDRD was 7.4 mL/min/ 1.73 m 2 lower than eGFR-CKD-EPI. It was especially lower at the intermediate range of eGFR from 60 to 110 mL/min/1.73 m 2 . The total number of risk factors for CKD or CVD (defined as hypertension, self-reported diabetes, prior CVD, obesity with BMI ≥ 30 kg/m 2 and central obesity with standardized waist ≥ 1 SD) was inversely correlated with eGFR but more closely with eGFR-CKD-EPI than with eGFR-MDRD, with Spearman's correlation coefficient of − 0.243 (P < 0.001) for eGFR-CKD-EPI and − 0.125 (P < 0.001) for eGFR-MDRD. The prevalence of these risk factors increased across the eGFR categories (0-1, 2 and 3-5) using both eGFR estimating equations (Supplementary Table 1) .
Logistic regression analysis, adjusted for age, gender, study year and study area, showed an association of hypertension, obesity, self-reported diabetes and prior CVD with eGFR Category 3-5 using both eGFR estimating equations ( Figure 3) , with slightly higher odds ratios for eGFR Category 3-5 defined by the CKD-EPI equation than by the MDRD equation. The highest odds ratio (1.91, 95 % CI 1.36-2.68) was observed for the , where k is 0.7 for females and 0.9 for males, α is − 0.329 for females and − 0.411 for males, min indicates the minimum of pCrea/k or 1 and max indicates the maximum of pCrea/k or 1 [7] . association of prior CVD with eGFR Category 3-5 by using the CKD-EPI equation.
The relationship between the 10-year risk of fatal CVD (SCORE) and eGFR by the two equations (Figure 4 The prevalence of concordant and discordant eGFR categories by the MDRD and CKD-EPI equations and estimated 10-year risk of fatal CVD for each category are presented in Table 3 . Estimated 10-year risk of fatal CVD had an increasing trend from lower to higher concordant eGFR categories (P for trend < 0.001). Out of all eGFR classifications, 26 % were discordant. Of subjects in eGFR Category 2 by the MDRD equation, 2691 (42 % ) belonged to eGFR Category 0-1 by the CKD-EPI equation.
Among subjects in discordant eGFR category with higher MDRD than CKD-EPI category (Category 2 by MDRD but Category 0-1 by CKD-EPI), the mean age was higher, the proportion of women was higher, the prevalence of smoking lower and the mean number of risk factors was similar in comparison with subjects in concordant Category 0-1 (Table 4) . Furthermore, the 10-year risk of fatal CVD was lower, suggesting that there was no excess risk among these subjects. In contrast, the prevalence of hypertension, prior CVD, mean number of risk factors, 10-year risk of fatal CVD, mean age and the proportion of men were higher in discordant category with higher CKD-EPI than MDRD category versus in concordant category. Our finding of higher prevalence figures of eGFR Category 3-5 when using the MDRD equation in comparison to the CKD-EPI equation is in line with previous observations [11, [13] [14] [15] [16] [17] [18] . White et al. have applied both the MDRD and the CKD-EPI equations in a similar sized population cohort. Using the MDRD Study equation, the prevalence of CKD was estimated to be higher (13.4 % ) than when using the CKD-EPI equation (11.5 % ) [19] . However, to our knowledge, there are no studies comparing these equations in assessing eGFR trends in representative population samples. In our study, the MDRD equation augmented the decreasing trend of eGFR between 2002 and 2007 at population level in comparison to the CKD-EPI equation.
In comparison to the results from the National Health and Nutrition Examination Surveys (NHANES) [20] , the prevalence of eGFR-MDRD < 90 mL/min/1.73 m 2 increased more in Finland (from 52.5 to 74.3 % ) from 2002 to 2007 than in the USA (from 44.5 to 55.5 % ) from 1988-1994 to 1999-2004; while at the same time, the prevalence of eGFR < 60 mL/min/1.73 m 2 increased less in Finland (from 2.6 to 4.5 % ) than in the USA (from 7.3 to 10.5 % ). The estimating equation had a substantial effect on the prevalence figures, especially on the prevalence of eGFR < 90 mL/min/1.73 m 2 ( Table 2 ). The MDRD equation is known to underestimate measured GFR around or above the upper levels at which the equation was derived [21] . Although opposite views Fig. 3 . The odds ratio (95 % CI) for risk factors associated with CKD screened in general population by the MDRD and the CKD-EPI equations after adjustment for age, gender, study period and study area.
have also been proposed [16] , some authors have considered the CKD-EPI equation to have a superior performance in comparison with the MDRD equation [6, 19] . When evaluating >50 000 patients identified in CKD Stages 3-5 on the basis of either the MDRD or the CKD-EPI equations, patient characteristics varied substantially depending on the equation applied including a 35 % decrease among patients < 60 years and a 10 % increase among patients >90 years when applying the CKD-EPI equation [22] . Additionally, women, non-diabetic people and obese people were less likely to become classified as having CKD on the basis of the CKD-EPI equation. The investigators concluded that further research is needed to determine whether widespread use of the CKD-EPI equation with current guidelines could lead to delayed care among younger patients or excessive referrals among older patients. Based on our study findings, the discordant eGFR categories to the direction of higher eGFR-MDRD than eGFR-CKD-EPI category presented people of low global risk factor score who were more often women than men. On the other hand, the discordant eGFR category to the direction of higher eGFR-CKD-EPI than eGFR-MDRD category included subjects of high age who were more often men than women with a high global CVD risk factor score.
The CKD-EPI equation has been considered to provide lower estimations of CKD prevalence than other GFR estimating equations [14] . Also in a west European Caucasian population, the CKD-EPI equation in comparison to the MDRD Study formula led to higher estimates of GFR in young people and lower estimates in the elderly [23] . On a population level, this may lead to overall higher estimates of kidney function, but in clinical practice among the elderly to underestimation of kidney function. Delanaye et al. The CKD-EPI equation has been considered to predict CVD and CKD risk more accurately than other GFR estimating equations [14] . In an Australian cohort study, an analysis on discrepant categories by the MDRD and CKD-EPI equations revealed that the lower estimated prevalence of CKD when using the CKD-EPI equation is caused by re-classification of low-risk individuals with no increase in mortality [19] . Furthermore, in an Italian study of type 2 diabetic patients, the subjects who had CKD based on the MDRD equation but not on the CKD-EPI equation proved to be low-risk individuals [18] . The difference between the CKD-EPI and the MDRD equations observed in our study is consistent with these findings. In our study, a substantial number of subjects were classified to a milder eGFR category according to the CKD-EPI equation in comparison to the MDRD equation. The CKD-EPI equation had a better capacity to capture variation of risk factor burden in comparison to the MDRD equation, also when assessed by the 10-year risk of fatal CVD.
Our study was carefully designed and the methodology was well standardized and validated. However, this study was not a prospective follow-up study. The two surveys were independent of each other, and therefore, the differences between the prevalence of CKD must be interpreted with caution [24] . The participation rates in the population surveys were exceptionally high. However, the surveys were cross-sectional, the measurements of creatinine were not repeated, urinary albumin measurement was not included in the surveys and the gold standard for GFR was lacking. As a residual confounding factor, the diagnosis of diabetes mellitus was based on self-reporting, whereby the prevalence of diabetes may be an underestimate. Additionally, it is possible that the bias in the measurements of creatinine explains a part of the difference between the mean eGFR levels between 2002 and 2007.
In comparison with the CKD-EPI equation, the MDRD equation augmented the trend of increasing prevalence of CKD. In this study based on the general population, a notable amount of people without an overload of CKD and CVD risk factors were re-classified to a better eGFR category by the CKD-EPI equation than by the MDRD equation. In search for suitable measures of screening for impaired renal function at the population level, not the accuracy per se but the capacity in predicting outcome and complications related to co-morbidities of CKD is of major importance. With the increasing frequency of mild renal impairment in populations, it is in the frontier for prevention in public health.
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